DBV Technologies (DBVT) Net Cash Flow (2020 - 2026)
DBV Technologies (DBVT) reported Net Cash Flow of $39.5 million for Q1 2026, up 296.52% year-over-year from $10.0 million in Q1 2025, and down 67.93% quarter-over-quarter from $123.2 million in Q4 2025.
DBV Technologies (DBVT) Net Cash Flow (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of Net Cash Flow data on file, last reported at $39.5 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at $39.5 million, up 296.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $213.2 million (up 342.7% YoY), and the FY2025 annual result was $153.6 million, up 246.81% from the prior year.
- Net Cash Flow fell to $39.5 million in Q1 2026 per DBVT's latest filing, from $123.2 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $184.9 million in Q2 2022 and troughed at -$36.9 million in Q1 2024.
- A 5-year average of $9.0 million and a median of -$20.1 million in 2025 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow slumped 1200.0% in 2023, then jumped 1242.17% in 2025.
- A 5-year view of Net Cash Flow shows it stood at -$24.2 million in 2022, then jumped by 41.9% to -$14.1 million in 2023, then gained by 23.31% to -$10.8 million in 2024, then jumped by 1242.17% to $123.2 million in 2025, then sank by 67.93% to $39.5 million in 2026.
- Business Quant data shows DBVT's Net Cash Flow at $39.5 million in Q1 2026, $123.2 million in Q4 2025, and -$32.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | 39.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.50 Mn |
| Mar 31, 2026 | 39.50 Mn |
| Dec 31, 2025 | 123.17 Mn |
| Dec 31, 2025 | 123.17 Mn |
| Sep 30, 2025 | -32.55 Mn |
| Sep 30, 2025 | -32.55 Mn |
| Jun 30, 2025 | 83.11 Mn |
| Jun 30, 2025 | 83.11 Mn |
| Mar 31, 2025 | -20.10 Mn |
| Mar 31, 2025 | -20.10 Mn |
| Dec 31, 2024 | -10.78 Mn |
| Dec 31, 2024 | -10.78 Mn |
| Sep 30, 2024 | -22.56 Mn |
| Sep 30, 2024 | -22.56 Mn |
| Jun 30, 2024 | -34.42 Mn |
| Jun 30, 2024 | -34.42 Mn |
| Mar 31, 2024 | -36.89 Mn |
| Mar 31, 2024 | -36.89 Mn |
| Dec 31, 2023 | -14.06 Mn |
| Dec 31, 2023 | -14.06 Mn |